We are live on ! Find out more
INSM icon

Insmed
INSM

271 hedge funds and large institutions have $4.69B invested in Insmed in 2023 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 91 increasing their positions, 88 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 25

26% more capital invested

Capital invested by funds: $3.72B → $4.69B (+$967M)

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

8% more funds holding

Funds holding: 252 → 271 (+19)

3.26% more ownership

Funds ownership: 102.49% → 105.75% (+3.3%)

3% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 88

81% less call options, than puts

Call options by funds: $10M | Put options by funds: $53.3M

Holders
271
Holders Change
+19
Holders Change %
+7.54%
% of All Funds
3.95%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.12%
New
48
Increased
91
Reduced
88
Closed
25
Calls
$10M
Puts
$53.3M
Net Calls
-$43.2M
Net Calls Change
-$10M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$62M
2
BlackRock
BlackRock
New York
+$28.6M
3
HRCM
Hood River Capital Management
Florida
+$23.5M
4
State Street
State Street
Massachusetts
+$22.7M
5
Marshall Wace
Marshall Wace
United Kingdom
+$22.7M

Top Sellers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$64.2M
2
BG
Bellevue Group
Switzerland
-$22.6M
3
SCM
Suvretta Capital Management
New York
-$19.8M
4
DTC
Deep Track Capital
Connecticut
-$16.9M
5
Millennium Management
Millennium Management
New York
-$14.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
DT
176
Diversified Trust
Tennessee
$639K +$25.2K +972 +5%
Qube Research & Technologies (QRT)
177
Qube Research & Technologies (QRT)
United Kingdom
$632K +$529K +20,397 New
AB
178
Amalgamated Bank
New York
$612K -$17.6K -679 -3%
Victory Capital Management
179
Victory Capital Management
Texas
$583K +$85.9K +3,311 +21%
BMSSC
180
B. Metzler seel. Sohn & Co
Germany
$579K +$53.2K +2,051 +12%
Creative Planning
181
Creative Planning
Kansas
$537K +$103K +3,985 +30%
EFM
182
E Fund Management
China
$532K +$81.2K +3,130 +22%
CUAMC
183
China Universal Asset Management Company
China
$513K +$333K +12,853 +348%
DIA
184
Dana Investment Advisors
Wisconsin
$484K +$6.87K +265 +2%
William Blair & Company
185
William Blair & Company
Illinois
$467K – – –
AIP
186
Ameritas Investment Partners
Nebraska
$443K +$31.4K +1,212 +9%
ET
187
Entropy Technologies
New York
$435K +$364K +14,026 New
Public Employees Retirement Association of Colorado
188
Public Employees Retirement Association of Colorado
Colorado
$432K – – –
SAM
189
Sectoral Asset Management
Quebec, Canada
$428K -$8.65M -333,581 -96%
PCM
190
Prelude Capital Management
New York
$415K – – –
TRCT
191
Tower Research Capital (TRC)
New York
$415K +$294K +11,342 +554%
EGM
192
Engineers Gate Manager
New York
$408K -$657K -25,328 -66%
Prudential Financial
193
Prudential Financial
New Jersey
$388K +$18.1K +698 +6%
Stifel Financial
194
Stifel Financial
Missouri
$386K -$30.8K -1,188 -9%
AI
195
Atom Investors
Texas
$365K -$11.3K -437 -4%
EP
196
Edgestream Partners
New Jersey
$364K +$305K +11,758 New
Allspring Global Investments
197
Allspring Global Investments
North Carolina
$353K -$208K -8,034 -41%
GCM
198
Graham Capital Management
Connecticut
$350K -$837K -32,297 -74%
VEA
199
Virtus ETF Advisers
New York
$350K -$116K -4,482 -28%
Nomura Holdings
200
Nomura Holdings
Japan
$341K +$286K +11,010 New
6 7
8
9 10

INSM Hedge Fund Activity: Q4 2023 in Review

271 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2023, worth a combined $4.69B — up 26% from $3.72B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new INSM positions and 25 closed out — a net gain of 23 holders — while 91 added to existing stakes and 88 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $62M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $64.2M.

  • 271 institutional investors held Insmed (INSM) as of Q4 2023, up from 252 in Q3 2023.
  • Funds reported $4.69B of Insmed stock for Q4 2023, up 26% quarter-over-quarter.
  • 48 funds opened new Insmed positions in Q4 2023 and 25 closed out, a net change of +23 holders.
  • The largest Insmed buyer in Q4 2023 was Morgan Stanley, an estimated $62M added.
  • The largest Insmed seller in Q4 2023 was T. Rowe Price Investment Management, an estimated $64.2M sold.

Based on aggregated 13F filings for Q4 2023.